Evidence map›Paper›PMID 37034706›Full record

ArticlebioRxiv : the preprint server for biology2023

The immune response to a fungus in pancreatic cancer samples.

K J Brayer, J A Hanson, S Cingam, C Martinez, S A Ness, I Rabinowitz

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 7 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

K J BrayerDepartment of Internal Medicine / Molecular Medicine, University of New Mexico, Albuquerque, NM.
J A HansonDepartment of Pathology, University of New Mexico, Albuquerque, NM.
S CingamDepartment of Internal Medicine/ Division of Hematology- Oncology, University of New Mexico, Albuquerque, NM.
C MartinezDepartment of Pathology, University of New Mexico, Albuquerque, NM.
S A NessDepartment of Internal Medicine / Molecular Medicine, University of New Mexico, Albuquerque, NM.
I RabinowitzDepartment of Internal Medicine/ Division of Hematology- Oncology, University of New Mexico, Albuquerque, NM.
University of New Mexico · US

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Mutations and Target Genes in Adenoid Cystic CarcinomaR01DE023222 · NIDCR · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Viswanathan Palanisamy · 2012 to 2026
$5.6M
Lab Automation for a Genomics Shared ResourcesR24OD035446 · OD · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI NESS, SCOTT A. · 2023 to 2023
$68k
NCI NIH HHS P30 CA118100NIH HHS R24 OD035446
6 · The paper itself

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a poor prognosis cancer with an .aggressive growth profile that is often diagnosed at late stage and that has few curative or therapeutic options. PDAC growth has been linked to alterations in the pancreas microbiome, which could include the presence of the fungus

Identifiers

PMID37034706
PMCPMC10081247
OpenAlexW4361227962

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.